PMEL and neoplasm: Opt-TRP1 showed the strongest protection, with 0–10 tumor nodules per lung compared with more than 150 in mock-treated mice, and opt-Gp100 was the weakest, with no significant difference in the number of tumor nodules compared with mock-treated mice.